Latest News and Press Releases

MIG Capital, through its MIG Fonds, is investing 3 million Swiss Francs (CHF) in the Swiss start-up which designs precision drugs against eukaryotic pathogens.Digitalis Ventures co-leads the round...

Les fonds permettront d’avancer dans la découverte de traitements potentiellement disruptifs, à action rapide, pour la dépression résistante aux traitements et d'autres troubles...

Proceeds to advance potentially disruptive, fast-acting therapeutics for treatment-resistant depression and other neuropsychiatric disordersFirst-in-class, non-addictive, non-hallucinogenic molecules...

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...

i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH and HIL-INVENT Ges.m.b.H. participated in the seed roundFunds will be used to accelerate a new generation of T cell therapies against solid tumors...

Cumulus Oncology raises £9m in seed financing Eos Advisory-led round includes new corporate investor the Scottish National Investment Bank Proceeds from the financing will be used to support Cumulus...

SINGAPORE, July 17, 2023 (GLOBE NEWSWIRE) -- SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”, NASDAQ: SAI), announced today that its subsidiary, Atomic Evolution Limited (doing...

Boulder, CO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Vitro3D, a volumetric 3D printing company capable of printing complex objects in seconds, has raised $1.3M in an oversubscribed seed round led by Buff...

VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) -- Novateur Ventures, a leading global life sciences advisory firm, announced it has participated in the $13.6M (£10.3M) seed investment...

MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Underdog Pharmaceuticals, a key investment of Michael Greve's rejuvenation biotech VC Kizoo, has closed a $10 million round of capital....